Abstract From 2012 to 2014 in Japan, 214 cases of motor vehicle collisions were attributed to the use of illegal drugs. In 93 out of 96 investigated cases, the causative agents were a variety of synthetic cannabinoids (SCs). These SCs can be classified into three groups according to the lineage of the chemical structures: (1) naphthoyl indoles, such as MAM-2201, (2) quinolinyl ester indoles, such as 5F-PB-22, and (3) indazole carboxamides, such as 5F-AB-PINACA, 5F-AMB, and 5F-ADB. These SCs became available sequentially with increasing cannabinoid CB 1 agonist potencies and reached a nationwide outbreak in the summer of 2014. They caused acute intoxication with impaired consciousness, anterograde amnesia (impaired memory), catalepsy with muscle rigidity, tachycardia, and vomiting or drooling soon after smoking. Drivers who had abused one of these SCs might unexpectedly experience the acute intoxication that caused uncontrolled driving. These SCs were generally difficult to detect from body fluid samples. It is thought that the highly lipophilic SCs disappear from the blood via rapid degradation by liver enzymes and selective accumulation into adipose tissues. Thus, much effort should be directed to the development of fast and sensitive chemical detection of the drug usage.
Introduction
Synthetic cannabinoids (SCs) are a diverse class of compounds that are designed to elicit selective agonist activities on cannabinoid CB 1 and/or CB 2 receptors. Originally, SCs were developed in an attempt to find potentially safer therapeutic agents. However, many SCs have recently emerged that possess new chemical structures, and are widely abused as recreational cannabis substitutes [1] . The outbreak of SCs has social ramifications, particularly relating to the increased number of motor vehicle accidents, which occur easily since SCs are inadvertently and handily used by drivers when they smoke herbal mixtures containing SCs. The hazardous effects on driving are evident from the inhibitory actions of SCs on the central nervous system, resulting in somnolence and retarded movements. In addition, other psychotropic and physical adverse effects of SCs [1, 2] may be involved in causing motor vehicle accidents.
In Japan, 214 motor vehicle collisions were attributed to the use of illegal drugs from 2012 to 2014 (as announced in an official Japanese document from the National Police Agency). The number of suspected cases was 19 in 2012, 38 in 2013, and explosively increased to 157 in 2014. Accordingly, the Japanese Government has tightened the regulations on illegal drugs, and the outbreak has apparently been suppressed from 2015 to the present. The investigative organizations have provided the author with evidence on 96 serious cases that took place from 2012 to 2014. Most of the suspected compounds were SCs, although it was difficult to establish a causal relationship between drug use and an accident because of the lack of human toxicological or pharmacokinetic data on newly identified compounds. Moreover, only limited data were available for laboratory tests in these cases, because blood testing requires a court-issued warrant in Japan, which is difficult and time-consuming to obtain. However, the timeline of detected substances, drivers' statements, and observed symptoms were useful for a better understanding of the detrimental effects of SCs on driving. In this review, the author summarizes the toxicological features of recent 'super-strength' SCs by grouping compounds found in the 96 cases and highlighting typical accidents. Table 1 summarizes the observational data on the 96 investigated cases. All accidents were caused by male drivers with an average age of 30.8 years, reflecting the distribution of illegal drug abusers in Japan. The accidents occurred mainly in metropolitan areas in 2012, but afterward spread to rural areas where automobiles are required for daily living. Four persons were killed in four tragic cases, and more than 110 persons were injured in 51 cases. The objective appearances of the drivers after the collision were collectively described as 'impaired consciousness' in 73 out of 96 cases (76%), but excited states such as agitation, shouting, confusion, and continuous stereotyped behaviors were reported in 16 cases (17%). The causative agents were mainly hypothesized to be chemical compounds detected in the drivers' belongings, such as pipes and herbal pieces. In 93 out of 96 cases, one or more SCs were found, sometimes in combination with cathinones or diphenidines. Only diphenidine or its derivative was detected in the remaining three cases. There was no case in which only cathinone derivatives were used. These results suggest that SCs were the primary cause of motor vehicle collisions in most of these cases.
Overview
However, only limited data were available about blood and urine concentrations of SCs in these cases (Tables 2  and 3 ), indicating that direct evidence of illegal SC use was obtained in only one third of all cases. Of the 20 cases in which SCs were used in combination with other psychostimulants, cathinones or diphenidines were detected in 12 cases, while SCs were identified in only five cases. These facts suggest the difficulty of detecting and profiling SCs in biological samples, because of the relatively small amount of intake, unknown metabolism, and possible instability in the human body.
Lineage and timeline of SC Figure 1 shows the quarterly timeline of illegal compounds detected over 3 years. In total, ten cathinones, two diphenidines, and 22 SCs were identified. Assuming that SCs are the principal cause of impaired driving, the timeline can be divided into three sections according to the common structure of the prevalent SC:
(1) Until 2013 spring when naphthoyl indoles, such as MAM-2201, were dominant. (2) Spring to winter 2013 when quinolinyl ester indoles, such as 5F-PB-22, were dominant. (3) 2014 when indazole carboxamides, such as 5F-AB-PINACA, became dominant. The following chapters deal with the transition of SCs with reference to the 12 typical cases of accidents, in which observational consequences are well-documented and clearer than other cases (Table 4) .
MAM-2201 and naphthoyl indoles
The first-generation SCs were naphthoyl indole derivatives, such as JWH-018, which are known as the main component of 'Spice' and 'K2' drugs [2, 3] . Some of these SCs have more potent affinity and efficacy than the natural cannabis ingredient D 9 -tetrahydrocannabinol (THC), enabling stronger in vivo pharmacodynamic effects at lower doses [1] . The classical naphthoyl indole SCs were banned oneby-one as 'designated substances' by the Pharmaceutical Affairs Act in Japan. Accordingly, more diverse derivatives, such as MAM-2201 and AM-2232 ( Fig. 2a) had emerged by 2012 [4] , thereby evading the regulations.
These new naphthoyl indole SCs were involved in ten cases of motor vehicle collisions, often in combination with cathinone stimulants. However, as seen in the typical cases 1 and 2 (Table 4) , naphthoyl indole SCs elicited excitation behaviors by itself, as reported in an intoxicated patient with MAM-2201 [5] .
The naphthoyl indole SCs were barely determined in blood samples and never detected in urine samples. This may be due to the following reasons: (1) rapid action and rapid disappearance from blood, as reported in a controlled administration study of JWH-018 [6] ; (2) high lipophilicity, as shown by a fatal case in which MAM-2201 was concentrated in the adipose tissue [7] ; (3) low dose, according to their strong potency. As for the CB 1 agonistic potency of MAM-2201, the IC 50 value in inhibiting excitatory synaptic transmission in mouse cerebellum was 2.5-and 3-times lower than WIN-55,212 and JWH-018, respectively [8] , demonstrating that MAM-2201 is stronger than the classical naphthoyl indoles. In addition, the mean concentration of MAM-2201 was reported to be 1.04 ng/g whole blood in Swedish recreational uses [9] , indicating that only 2.8 nM blood concentration is sufficient to elicit cannabis-mimetic actions.
These naphthoyl indole SCs were banned by the structure-based, inclusive regulation of 2013 spring, and they disappeared from the Japanese illegal market.
5F-PB-22 and its analogs
Before the disappearance of naphthoyl indoles, a new type of SCs with quinolinyl ester indole and indazole NM-2201 5F-NPB-22 FDU-PB-22 AB-PINACA NNE-1 5F-AB-PINACA AB-FUBINACA 5F-AMB AB-CHMINACA MN-18 5F-ADB 5F-ADB-PINACA ADB-CHMINACA Even after the crash, the driver did not step off the accelerator pedal, but kept on moving the steering wheel and gear lever in a stereotyped manner. Driver had no memory of abnormal driving 5F-PB-22 and NNE-1 were detected in the herbal material. Blood was sampled 17 h after the crash, and 0.39 ng/mL 5F-PB-22 was detected 6 1401 29 A driver received a parcel containing a herbal drug at a post office and immediately smoked in his car. Six minutes after smoking, his car went straight on a curve road at 36 km/h and drove into the opposite lane. A child walking on the opposite sidewalk after the school was hit and the child died
The driver kept grasping the steering wheel and did not respond to bystanders' shouts. Driver had no interest in the car crash. Emergency crew identified traces of vomiting. After 25 min, the driver recovered and could walk by himself. He had no memory of the crash 5F-AB-PINACA was detected in the herbal mixture, but not in the blood sample taken after 49 h after the crash 7 1402 37 Two persons smoked herbal drugs while driving a sports utility vehicle. When a police patrol car followed their car at a red crossing signal, the car suddenly ran away into the narrow space between the leading vehicles. Ten cars were damaged and 12 persons were injured
The driver exhibited impaired consciousness with slow movements. His reaction turned to 'crazy' excitation and agitation during inspection by police. Driver had no memory of the crash but could recall the place of smoking FUB-PB-22 (1.74 ng/mL) was detected from a blood sample taken 75 min after the crash. In addition, 5F-AMB, THJ-2201, and AMB were detected in the herbal mixture 8 1404 28 A driver was a long-term abuser. He ignored a red light at 80 km/h and caused successive vehicle collisions. Eight persons were injured
The driver was awake but motionless, and he did not respond for 10 min. He started moving 15 min after the crash and responded by talking thereafter. Driver had no memory of the crash 5F-AMB was detected in the herbal mixture and in the blood sample taken 14 h after the crash (but was not quantified) 9 1405 19 Two persons took turns smoking herbal blends while driving. At a crossing, the car suddenly jump-started into the opposite lane, reaching 100 km/h. The car drove more than 100 m and caused several head-on crashes one after another. One young man was killed and two persons were injured Driver exhibited impaired consciousness with drooling and a heart rate of 123 beats/min. Driver had no memory of the jump-start but he remembered smoking. The passenger ran away 5F-AMB was detected in urine samples of the driver and passenger 10 1406 37 On a busy downtown street, a car drove on a wide sidewalk for 30 m and hit many walkers one after another until it was stopped by collision with a telephone booth. One young lady was killed and seven persons were injured Driver lost consciousness and was drooling. He had no memory of what occurred after smoking 5F-AMB and AB-CHMINACA were detected in the herbal mixture. In addition, 5F-AB-PINACA was detected in the urine sample Forensic Toxicol (2017) 35:244-251 247 carboxamide backbone structures emerged [10] . Among them, 5F-PB-22 ( Fig. 2b ) was involved in all 15 cases during the half-year from April to September 2013 until it was banned as a designated substance. 5F-PB-22 was 100 and 36 times more potent than WIN-55,212 and JWH-018, respectively, in a functional agonist assay using recombinant human CB 1 receptor [11] . A longterm abuser who had been accustomed to naphthoyl indole SCs might become easily intoxicated after routine smoking of herbal blends containing the new ingredient that was stronger than before, as seen in the cases 3, 4, and 5 (Table 4) . Catalepsy with muscle rigidity was the characteristic acute symptom in these cases, which may be the direct cause of accidents.
5F-PB-22 was detected from blood samples in six cases, and could be determined in five cases with a range of 0.274-0.93 ng/mL ( Table 2 ). The average concentration of 0.45 ng/mL is equivalent to 1.2 nM, suggesting its strong toxicity. In four postmortem cases, the observed concentration range of 5F-PB-22 was 1.1-1.5 ng/mL [12] , indicating that the toxic dose for driving is close to the lethal dose. Because 5F-PB-22 is highly lipophilic, and the predominant metabolic pathway of 5F-PB-22 in human hepatocytes is ester hydrolysis yielding a wide variety of metabolites [13] , it is difficult to identify its unchanged form or metabolites in urine. Indeed, 5F-PB-22 was never detected in urine samples.
After 5F-PB-22 was banned, several derivatives of 5F-PB-22, such as FUB-PB-22 and NM-2201 (Fig. 2b ) appeared and were used in 2014. Although these SCs were involved in a number of cases (Fig. 1) , including cases 7 and 11 (Table 4) , their pharmacodynamic and pharmacokinetic data are currently unavailable.
5F-AB-PINACA, 5F-AMB and their analogs
From the end of 2013, SCs with indazole carboxamide backbones have become predominant (Fig. 2c) . This type of SCs was the strongest CB 1 agonist and seemed to be designed and modified according to a patent applied by Pfizer [14] .
5F-AB-PINACA was involved in 11 cases from 2013 December to 2014 April until it was banned. 5F-AB-PINACA is 38 and 360 times more potent than JWH-018 and THC, respectively, in a functional agonist assay using recombinant human CB 1 receptor [15] . Accordingly, as seen in case 6 (Table 4) , use of 5F-AB-PINACA while driving caused abrupt intoxication accompanied by catalepsy, vomiting, and loss of consciousness. Later, AB-CHMINACA, a similar compound with a cyclohexyl ring, appeared and was involved in 11 cases.
A nationwide outbreak of SC use occurred in the summer of 2014 with 5F-AMB and 5F-ADB featuring L-valinate and L-tert-leucinate, respectively, in the pendant group (Fig. 2c) . 5F-AMB and 5F-ADB are 90 and 300 times, respectively, more potent than THC as full agonists for the human CB 1 receptor [16] .
5F-AMB was involved in 21 cases, including several tragic collisions such as cases 8-11 (Table 4) . In serious cases, catalepsy was accompanied by muscle rigidity in the extremities, which provoked abrupt acceleration of the car without braking or controlling the steering wheel. Catalepsy is characterized in rodents as prolonged motionless at unnatural posturing and known as one of the tetrad of cannabinoid actions together with lowered body temperature, antinociception, and decreased spontaneous locomotion. These symptoms were also observed when mice were Driver was found wandering around the car with impaired consciousness. He had no memory of driving from 2 min before the car started weaving 5F-AMB (0.07 ng/mL) and FUB-PB-22 (0.79 ng/mL) were detected in the blood sample taken 10 h after the crash. In the urine, 5F-AMB and THC were detected 12 1409 30
The driver was a long-term abuser for more than 3 years and never experienced memory loss. However, after a brief smoking of 'Heart Shot Red', he lost memory. Within 5 min, his car crashed into a parked car Driver lost consciousness, but recovered within an hour. He had a heart rate of 106 beats/min with tachypnea 13 min after the crash 5F-ADB was detected in the urine, saliva and hair. 4F-a-PHPP was detected in the blood yymm first two figures show the year and last two the month injected with AB-CHMINACA or AB-PINACA [17] . The rodent catalepsy recovers by external stimulus such as airpuff or sound, and they were reportedly mediated by decreased 5-HT transmission in the basal ganglia [18] . In contrast, in humans, strong SCs causes more severe, irreversible catalepsy with muscle rigidity, high body temperature, tachycardia, and vomiting. As these symptoms resemble the serotonin syndrome, the author and colleagues investigated the effect of 5F-ADB on midbrain serotonergic neurons. However, 5F-ADB did not affect serotonergic activity; rather, dopaminergic firings were readily increased [19] . Therefore, the neuronal mechanism underlying catalepsy seen in SC abuser is unclear. The 'final boss' 5F-ADB was detected in the most frequent 24 cases, but fortunately, without a serious case. This may be because too much 5F-ADB was added to the herbal products, and drivers could not drive very far after smoking before losing consciousness, as seen in case 12 (Table 4) . Accordingly, vomiting or a trace of vomiting was frequently observed in impaired drivers in 14 out of 23 cases involving 5F-ADB. It is also known that many people died in 2014 by smoking herbal products containing excess amounts of 5F-ADB (unpublished observation). Many news reports showing the dangerous effects of illegal drugs also helped to suppress the recreational uses. All these SCs were banned by the end of 2014.
An apparent difference in the action of this class of SCs was the time required for recovery from impaired consciousness. Users of naphthoyl indoles and quinolinyl ester indoles required more than an hour to communicate normally with other persons. However, drivers taking indazole carboxamide SCs frequently showed rapid recovery within an hour. It has been reported that 5F-AMB is quickly hydrolyzed by hepatic esterase [20] , while 5F-AB-PINACA is more slowly metabolized to various products [21] . The rapid recovery seen in this class of SC remains mysterious.
Another characteristic of indazole carboxamide SCs is the detection from urine samples (Table 3) . Increased polarity of the chemical structures may have contributed to the solubility of the compounds in aqueous solution. However, detection from blood samples was rare in this class of SC because the low dose and fast metabolism made the concentration in blood undetectable.
In a series of studies analyzing indazole carboxamide SCs in remaining human cadavers [22] [23] [24] , 5F-AMB was mostly concentrated in the adipose tissue, while 5F-ADB and AB-CHMINACA were more widely distributed in other organs, such as brain and heart muscles. These SCs were never detected in the blood and urine, whereas MAB-CHMINACA (also called ADB-CHMINACA) was present in the blood as much as in other organs, although not in the urine. The mechanisms underlying distribution, metabolism, and excretion of SCs may be diverse and need to be investigated individually in detail.
Concluding remarks
The most striking and almost common statements of SCabused drivers are that they did not remember the collision scene, including before and after, although there may be some doubt on the drivers' statements in themselves. The driver could drive properly (to some extent) with his eyes open while he could not remember what he was doing prior to the collision, suggesting that use of SCs caused anterograde amnesia that disabled new learning.
Most drivers seemed to be accustomed to using illegal drugs on some level and routinely used SC products while driving. However, the quality control of illegal products is so inaccurate and inconsistent that some packages might contain a huge amount of SC, as reported in the case of 5F-ADB [23] , which might cause unexpected intoxication in a driver, instantly leading to uncontrolled driving. Because the clinical signs observed in the abused drivers are transient in conjunction with the disappearance of active compounds from the body fluid, prosecution cannot be solely based on the material evidence. Much effort should be directed to the development of fast and sensitive chemical detection of drug usage.
The outbreak of SC is just like cyber-terrorism, wherein a wise scientist turns into a smart evil one. Given that the science extends its capability infinitely, we must keep in mind that there may be another outbreak of different kinds of illegal drugs.
